Open Access

Physical activity and FTO genotype by physical activity interactive influences on obesity

  • Joon Young Kim1,
  • Jacob T. DeMenna2,
  • Sobha Puppala3,
  • Geetha Chittoor4,
  • Jennifer Schneider3,
  • Ravindranath Duggirala5,
  • Lawrence J. Mandarino2, 6,
  • Gabriel Q. Shaibi1, 6, 7 and
  • Dawn K. Coletta2, 6Email author
BMC GeneticsBMC series – open, inclusive and trusted201617:47

https://doi.org/10.1186/s12863-016-0357-6

Received: 13 November 2015

Accepted: 17 February 2016

Published: 24 February 2016

Abstract

Background

Although the effect of the fat mass and obesity-associated (FTO) gene on adiposity is well established, there is a lack of evidence whether physical activity (PA) modifies the effect of FTO variants on obesity in Latino populations. Therefore, the purpose of this study was to examine PA influences and interactive effects between FTO variants and PA on measures of adiposity in Latinos.

Results

After controlling for age and sex, participants who did not engage in regular PA exhibited higher BMI, fat mass, HC, and WC with statistical significance (P < 0.001). Although significant associations between the three FTO genotypes and adiposity measures were found, none of the FTO genotype by PA interaction assessments revealed nominally significant associations. However, several of such interactive influences exhibited considerable trend towards association.

Conclusions

These data suggest that adiposity measures are associated with PA and FTO variants in Latinos, but the impact of their interactive influences on these obesity measures appear to be minimal. Future studies with large sample sizes may help to determine whether individuals with specific FTO variants exhibit differential responses to PA interventions.

Keywords

Genetic variations Physical activity Obesity-related phenotypes Latinos

Background

There has been a global increase in the prevalence of obesity across all age groups and it has become a serious health problem as it contributes to the increasing burden of obesity-related comorbid health conditions such as type 2 diabetes and cardiovascular disease [1]. It is well established that individual susceptibility to obesity is determined by the interplay between a genetic component and environmental factors [2]. Since the first identification of the fat mass and obesity-associated (FTO) as an obesity-susceptibility gene by Frayling et al. [3], numerous genome-wide association studies (GWAS) have been performed in order to confirm the association between FTO single nucleotide polymorphisms (SNPs) and obesity-related phenotypes in several populations [4, 5]. More recently, we demonstrated significant heritability estimates of obesity-related phenotypes in our Latino population, and confirmed strong associations to obesity-related traits for the FTO SNPs [6].

With consistent replications of the associations between FTO genetic variants and obesity-related phenotypes, it is of growing interest whether these genetic effects on obesity are modified by lifestyle factors such as physical activity (PA). Although some studies have not observed interaction effects between PA and the FTO SNPs on obesity [7, 8], a detailed meta-analysis by Kilpelainen et al. supports the rigid evidence that PA attenuates the effect of the FTO genetic variants on obesity by analyzing data from 218,166 adults from 45 studies [9]. However, to date, there is a lack of evidence in Latinos who are known as a higher risk population for obesity and type 2 diabetes [10]. Although there are a handful of studies with mixed populations, including Latinos, these studies including our own [6], have only examined the association between FTO genetic variants and obesity-related phenotypes such as body mass index (BMI), waist circumference, or body composition [5, 1113].

Therefore, the purpose of this study is to examine whether regular PA modifies the effect of the variations in the FTO gene on obesity risk, as measured by BMI, fat mass, hip circumference, and waist circumference in a Latino population.

Results

The descriptive characteristics of the study participants have been reported previously [7]. Briefly, among 667 participants with mean age of 31.7 ± 13.4 (aged 7–85 years old), 80 % of the study population were adults (>18 years old) and 61 % were female. The prevalence of type 2 diabetes in our population was 12.3 and 34 % of the participants were classified with prediabetes (impaired fasting glucose or impaired glucose tolerance). The FTO SNP association analysis data from our previous study [7] demonstrated that the three FTO SNPs (rs3751812, rs8050136, and rs9939609) were in the HWE and in strong LD with r2 ranging from 0.87 to 0.98. The minor allele frequencies of the three FTO SNPs ranged from approximately 23 to 26 %. Briefly, as shown previously [7], heritability estimates for BMI, hip circumference, and waist circumference were significantly moderate in magnitude (range 0.34–0.39) and those phenotypes were significantly associated with FTO SNPs (rs3751812, rs8050136, and rs9939609). In addition, in the current study, heritability estimates for fat mass was determined using SOLAR and was also moderate in magnitude and significant (h2 = 0.43 ± 0.11, P < 0.0001). Minor alleles of the three FTO SNPs (rs3751812 [T], rs8050136 [A], and rs9939609 [A]) were significantly associated with higher levels of fat mass (all P < 0.01). There were no significant association between three FTO SNPs and PA [PA-Yes and PA-No] (rs3751812: P = 0.645, rs8050136: P = 0.541, and rs9939609: P = 0.538).

Effect of PA on obesity-related phenotypes

The descriptive characteristics by PA group are presented in Table 1. The number of participants who reported that they participated in regular PA was 389 (58.9 %), while 271 (41.1 %) reported that they did not participate in regular PA. Participants who participated in regular PA were slightly younger and more likely to be males (Table 1). After adjusting for the covariate effects of age and sex, participants who engaged in the regular PA exhibited significantly lower BMI, fat mass, hip circumference and waist circumferences, all P < 0.05 when compared to those who did not engage in the regular PA. Likewise, in all heritability analyses, which accounted for age and sex effects, the covariate screening found that PA is a strong correlate of BMI (P = 0.002), fat mass (P = 0.00007), hip circumference (P = 0.004), and waist circumference (P = 0.00006).
Table 1

Descriptive characteristics of participants by groups (“yes” responders vs. “no” responders at regular PA questionaire)a

 

PA-Yes (n = 389)

PA-No (n = 271)

Total (n = 660)

P-value

Age (years)

31.1 ± 13.6

33.1 ± 13.0

31.7 ± 13.4

0.053

Sex (male/female), n (%)

186 (48)/203 (52)

71 (26)/186 (74)

260 (39)/407 (61)

<0.001

BMI (kg/m2)b

27.9 ± 6

30.1 ± 7.3

28.8 ± 6.6

<0.001

Fat mass (kg)b

20.4 ± 10.3

25.4 ± 12.1

22.4 ± 11.3

<0.001

Hip circumference (cm)b

104.6 ± 12.4

108.5 ± 14.6

106.1 ± 13.5

<0.01

Waist circumference (cm)b

93.3 ± 15.2

98.5 ± 16.8

95.3 ± 16.1

<0.001

Data are mean ± SD unless otherwise indicated. A total of 667 participants participated in the study. Of the 667 participants, data for PA questionnaire, body mass index (BMI), fat mass, hip circumference and waist circumference were not available for 7, 3, 8, 7, and 7, respectively

aNot accounted for the relatedness of study participants; bAdjusted for age and sex effects

Interaction effect of the three FTO SNPs and PA on obesity-related phenotypes

Table 2 describes the interaction effects of the three FTO SNPs and PA on BMI, fat mass, hip circumference, and waist circumference after adjusting for age and sex. None of the interaction terms were found to be significant (P < 0.05) as revealed by the genetic analyses. However, a trend can be seen toward significance in the interaction effects between the three FTO SNPs and PA on BMI, fat mass, and hip circumference. For example, regarding the SNP rs3751812, its interactive influences with PA on BMI are suggestive (P = 0.08). As shown in Table 2 and Fig. 1, a trend can be observed wherein the carriers of FTO minor (risk) alleles at the three examined loci who are engaged in regular PA are at reduced obesity risk compared to those rare variants carriers who are associated with decreased levels of PA. For example, regarding the marker rs3751812, after taking the SNP and interaction influences into account, the carriers of risk allele “T” engaged in regular PA exhibited reduced obesity risk as shown by the effects in units of BMI (SE) by risk allele carrier status compared to those not engaged in regular PA: Heterozygous carriers: PA-Yes = 0.855 ± 0.254 versus PA-No = 2.729 ± 0.703 and Homozygous carriers: PA-Yes = 1.791 ± 0.507 versus PA-No = 5.457 ± 1.406.
Table 2

Interaction between PA and FTO SNPs on adiposity-related phenotype

SNP rs no.

Phenotype

Major/major

Major/minor

Minor/minor

Pa

PA_Yes

PA_No

PA_Yes

PA_No

PA_Yes

PA_No

rs3751812 (G/T)

BMI

27.8 ± 6.1

28.9 ± 6.4

28.2 ± 5.7

31.2 ± 7.1

30.9 ± 4.8

37.3 ± 8.3

0.08

Fat mass

20.2 ± 10.9

24.2 ± 11.6

21.1 ± 9.7

27.5 ± 12.8

26.3 ± 8.5

38.4 ± 16.5

0.12

HC

104.2 ± 12.7

106.5 ± 13.3

105.5 ± 11.5

110.9 ± 13.7

111.2 ± 9.8

122.7 ± 16.1

0.13

WC

92.7 ± 15.3

96.5 ± 16.3

94.2 ± 14.7

100.4 ± 16.1

102.5 ± 13.3

111.5 ± 19.4

0.46

rs8050136 (C/A)

BMI

28.0 ± 6.1

28.9 ± 6.5

27.9 ± 5.7

30.9 ± 7.0

30.7 ± 4.9

34.7 ± 9.0

0.14

Fat mass

20.5 ± 11.0

24.4 ± 11.8

20.6 ± 9.7

27.1 ± 12.6

25.4 ± 8.6

33.2 ± 17.4

0.10

HC

104.6 ± 12.5

106.6 ± 13.4

104.8 ± 12.0

110.4 ± 13.7

109.9 ± 10.0

118.3 ± 16.8

0.14

WC

92.9 ± 15.2

96.8 ± 16.6

93.8 ± 14.9

100.0 ± 15.9

100.7 ± 14.3

105.8 ± 20.8

0.61

rs9939609 (T/A)

BMI

27.9 ± 6.2

28.8 ± 6.4

28.0 ± 5.7

30.9 ± 7.0

30.6 ± 4.8

34.7 ± 9.0

0.60

Fat mass

20.4 ± 11.1

24.3 ± 11.8

20.8 ± 9.6

27.1 ± 11.8

25.3 ± 8.4

33.2 ± 17.4

0.17

HC

104.4 ± 12.8

106.4 ± 13.2

105.0 ± 11.7

110.3 ± 13.6

109.9 ± 9.7

118.3 ± 16.8

0.21

WC

92.7 ± 15.5

96.6 ± 16.6

94.1 ± 14.6

100.0 ± 15.8

100.2 ± 14.1

105.8 ± 20.8

0.78

Data are mean ± SD unless otherwise indicated. SNP rs no (Major allele/Minor allele) and bold allele indicates risk allele; BMI, body mass index; HC, hip circumference; WC, waist circumference. rs3751812 (major allele [G]; minor allele [T]); rs8050136 (major allele [C]; minor allele [A]); rs9939609 (major allele [T]; minor allele [A])

aP-values from the genetic analyses regarding the significance of the intercation terms

Fig. 1

Interaction between PA and FTO SNP rs3751812 on adiposity-related phenotypes. Major allele (G)/minor allele (T); minor allele T considered risk allele

When the three genotype categories of a given SNP were dichotomized as risk allele carriers (at least more than one risk allele) vs. no carriers; the carriers of the rare allele who participated in regular PA exhibited more clearer pattern of low obesity risk compared to those carriers that did not engage with regular PA (data not shown). As reported in Fig. 1, individuals with minor/minor alleles (considered as carrying two risk alleles) who were engaged in regular PA exhibited the largest reduction at BMI, fat mass, and hip circumference compared to the counterparts (21, 46, and 10 %, respectively). Thus, the homozygous carriers of the minor alleles with no PA appear to be at greater risk for obesity compared to the others.

Discussion

In the present study, we demonstrated that the obesity measures BMI, fat mass, hip circumference, and waist circumference are correlated with PA as well as with three FTO variants, and that there was some trend toward significance in the interaction effects between PA and FTO genetic variants on these four obesity-related phenotypes in a Latino population. Participants who did not engage in regular physical activity and were carriers of risk allele (minor allele) in the FTO gene exhibited higher BMI, fat mass, and hip circumference, although such relationships lacked statistical significance. In addition to confirming previous association studies in FTO related obesity risk; our data further suggest that PA may modify the genetic effect of FTO on the obesity-related risk in Latino children and adults, given that the examined FTO variants are not associated with PA in our sample.

FTO is the fat mass and obesity-associated gene but, in spite of its name, the exact physiological function of FTO is not well known. The human FTO gene is a 9-exon gene (covering more than 400,000 base pairs) located on human chromosome 16 and encodes a 2-oxoglutarate-dependent nucleic acid demethylase [14]. It has been widely demonstrated that the FTO gene may play an important role in energy homeostasis by regulating either energy expenditure or energy intake in humans [15, 16]. In addition, FTO has been described as a regulator of adipose tissue metabolism (i.e. lipolysis), as it contributes to the regulation of fat mass [17]. Further, a recent review not only supports the physiological role of FTO, but also introduces the novel biological function of FTO in epigenetic regulation [18]. Continuous efforts have been conducted to further clarify the functional role of FTO and it seems that previous work may reasonably support the mechanism underlying the link between FTO genetic variants and obesity.

The association between FTO genetic variants and obesity has been well replicated and established across ethnicities, but the main focus has been on those of European ancestry [3, 4]. Although limited data have been reported in Latino populations, several studies ( GWAS and replication studies) with mixed populations including Latinos have also exhibited the association between FTO genetic variants and obesity measures [5, 1113, 19]. Scuteri et al. [5] first found the SNP rs9930506 in relation to BMI, hip circumference, and weight in 839 Hispanic American in the GenNet study. Other groups have attempted not only to replicate previous findings, but also to find more associations of FTO SNPs with other adiposity-associated variables such as computed tomography-derived measures of adiposity [11], adipose tissue distribution [13], and measures of glucose homeostasis [19] in multi-ethnic groups including Hispanic populations. Recently, we demonstrated significant heritability estimates of obesity-related phenotypes in our Latino population, and confirmed strong associations to obesity-related traits for the FTO SNPs [6].

As previously mentioned, lifestyle factors such as PA and diet contribute to the obesity epidemic and may interact with genetic effects to modify the risk for obesity [20]. A growing number of studies have recently examined whether there are interaction effects between those lifestyle factors and FTO genetic variants on obesity risk. Interestingly, in terms of food intake and weight control, many studies have been in agreement with not only the association between FTO genetic variants and food intake [21] or increased appetite [22], but also the interaction effects of diet components with FTO SNPs on obesity risk [23]. In addition, a growing number of studies have reported that physical inactivity confers an increased risk of FTO genetic predisposition to obesity while physically active participants who have risk allele(s) of FTO SNPs exhibited lower risk for obesity [9, 24]. These data suggest that PA may be a moderator of the deleterious (i.e. risk-increasing) effects of FTO genetic variants on the risk for obesity. Our data suggest that regular PA may modify the effect of FTO genetic contribution to the obesity risk including BMI, fat mass, and hip circumference. It is possible that changes in waist and hip circumferences in response to regular PA or exercise may differ by sex [25]. Since the proportion of females in this study was 61 %, we did somewhat expect that the interaction effects of PA may differ between hip circumference and waist circumference.

To our knowledge, the majority of interaction studies have focused on European populations [9, 26] and a lack of data exist in the Latino population, even though it is well established that Latinos are at increased risk for obesity and type 2 diabetes [10]. Therefore, our data are relevant as we exclusively focused on Latino children and adults. In the current study, it is important to note that participants were asked whether they engage in regular PA. We did not measure PA levels nor did we define active or inactive individuals based upon some established reference such as the 2008 Physical Activity Guidelines for Americans, a scientific evidence-based update on the health benefits of a physically active lifestyle, released by the U.S. Department of Health and Human Services [27]. Our interpretation of moderating regular PA effect on the association between FTO genetic variants and obesity may provide a more realistic message to minority populations, suggesting that regular or habitual PA, of any amount, may be more effective at attenuating the FTO genetic effects on obesity than recommending a specific amount of PA that may be tied to general health [28]. Therefore, from a clinical or public health perspective, our data may help to emphasize the importance of daily healthy lifestyle or behaviors for reducing the genetic predisposition for obesity risk.

Despite these strengths, we do acknowledge potential limitations in our data which should be considered for proper interpretation of our findings. Two notable limitations are the small sample size used to assess interaction influences in this study compared to those used in the current large-scale association studies [29], and the use of the questionnaire-based PA assessment which can be affected by study participant recall bias [30]. It should be noted that the PA questionnaire used in the present study does not allow quantify how much PA is needed to reduce the effect of FTO on obesity-associated phenotypes. Given the issue of small sample size and low power, further studies of a larger cohort are warranted to detect lifestyle effects including PA as a moderator on the genetic effects of obesity. Also, we do not know whether the interaction effects are over- or under-estimated because of the accuracy of PA measurement [31]. Participants’ PA levels in the current study were simply measured by participant recall, which was not objectively quantified. Since our main purpose of the AIR registry is to develop a biorepository to examine cardiometabolic disease risk in the Latino population [32], lack of detailed information exists in the screening of lifestyle or environmental factors such as PA, diet/nutrition, and socioeconomic status. However, our data provide evidence for the utility of a simple PA screener in comparing obesity risk factors between PA groups, suggesting that current PA screeners can be used to explore the interaction effects of genetic variants on the obesity measures.

Conclusions

Our study highlights the possibility that genetic susceptibility to obesity may be modified by engaging in regular physical activity (regardless of whether an individual meets current PA guidelines). From a public health perspective, our findings are highly relevant with respect to our focus on a Latino population with disproportionately increased risk for obesity and type 2 diabetes [3336]. It is likely that this group is genetically predisposed to obesity and obesity-related comorbid conditions. Encouraging any physical activity in genetically susceptible individuals in order to mitigate the deleterious effects of obesity on health may be a more effective approach. Future studies are warranted to examine whether there are age- or sex-specific differences in the extent of interaction effects or whether individuals with specific FTO variants exhibit differential response to PA interventions.

Methods

Participants

Data from 667 Latino children and adults (aged 7–85 years old) from the Arizona Insulin Resistance (AIR) registry were used in the present analysis. The principal investigator and the ad hoc scientific steering committee of the AIR registry granted access to the specimen and data for this study. A description of the registry, the phenotypic characterization of the AIR participants and the procedures for gaining access to the data have been discussed in detail elsewhere [32]. Briefly, of the 667 participants enrolled in the study, 365 were distributed across 92 families from the AIR registry. The 365 participants from 92 families generated 723 relative pairs that were distributed across fourteen relative-pair categories [6]. The remaining 302 participants were found to be represented by single individuals. The institutional review board of Arizona State University approved all procedures, and all subjects gave informed written consent before any research procedures. Once youth (ages 7–18 year old) were in agreement for the participation, written consents (child assent and parental consent) were obtained.

Measurements, physical activity questionnaire, and SNP genotyping data

Participants arrived at the Arizona State University Clinical Research Unit after an overnight fast followed by screening of their medical history. Additionally, participants were asked whether they are engaged in regular physical activity (i.e. participants answered either yes or no). A complete intake questionnaire used in the AIR registry is shown in Additional file 1. Six-hundred and sixty participants had complete PA data. Anthropometric measurements included height, weight, BMI, hip circumference, and waist circumference. Bioelectrical impedance analysis was performed to estimate body composition (fat mass). All procedures were approved by the institutional review board of Arizona State University and all participants gave informed written consent before their participation.

Participants were divided into two PA groups (PA-Yes; participants who engaged in the regular PA vs. PA-No; those who did not engaged in regular PA) for analysis of the main effect of PA on obesity risk as well as the interaction effect of PA with FTO SNPs on obesity risk. To normalize the distributions for genetic analyses, BMI, fat mass, waist and hip circumferences were transformed using inverse normalization. Untransformed data are presented for ease of interpretation.

The SNP genotyping association analysis for the FTO variants (rs3751812, rs8050136, and rs9939609) with adiposity measures (excluding fat mass) have been previously published [6]. The FTO SNP data for all participants was used in the present study to determine the interaction effect with PA on measures of adiposity.

Statistical analysis

All statistical genetic analyses were performed using the variance components (VC) approach as implemented in the software package Sequential Oligogenic Linkage Analysis Routines (SOLAR) [solar.txbiomedgenetics.org] [37]. The heritability of a given phenotype is determined using the VC technique (SOLAR), and a likelihood ratio test is used to test whether the heritability of a given phenotype is significant (P < 0.05). Covariates age and sex are simultaneously controlled for in all analyses. In addition, all models included PA as a covariate, and a likelihood ratio test is used to assess its significance (P < 0.05).

The associations between the FTO genotypes and adiposity related quantitative traits are examined using the measured genotype approach (variance components [VC] MGA) within the analytical framework, which allows us to account for the non-independence among family members [37, 38]. Our previous association analyses for the FTO variants has been described in detail elsewhere [6]. Briefly, in the VC approach, variance components are modeled as random effects, whereas the effects of measured covariates such as age and sex are modeled as fixed effects on the trait mean. The variant genotypes are incorporated in the mean effects model as a measured covariate assuming additivity of allelic effects [38]. Maximum likelihood techniques are used to estimate the variance components, the association parameters, and the other covariate effects. The hypothesis of no association is tested by comparing the likelihood of a model, in which the effect of the measured genotype is estimated with a model, where the effect of the measured genotype is fixed at zero. We have extended this approach to assess genotype x PA interaction influence on a given obesity measure by allowing SNP genotype, PA, and SNP genotype x PA interaction as fixed effects. All analyses included age and sex terms as additional covariates. The hypothesis of no interaction between SNP genotype and PA on a given obesity measure is tested by comparing the likelihood of a model, in which the effect of the interaction term is estimated with a model, where the effect of the interaction term is fixed at zero. For these analyses (i.e., association or interaction), P values < 0.05 are considered statistically significant.

SOLAR was also used to calculate the allele frequencies, to test deviations from Hardy-Weinberg Equilibrium (HWE), and to estimate linkage disequilibrium (LD) between SNP pairs using r2 values. For the purpose of illustration, at some instances, data are described using the program SPSS without taking the relatedness of study participants into account.

Abbreviations

AIR: 

Arizona Insulin Resistance

BMI: 

body mass index

FTO: 

fat mass and obesity-associated

GWAS: 

genome-wide association studies

HWE: 

Hardy-Weinberg Equilibrium

LD: 

linkage disequilibrium

MGA: 

measured genotype approach

PA: 

physical activity

SNPs: 

single nucleotide polymorphisms

SOLAR: 

Sequential Oligogenic Linkage Analysis Routines

VC: 

variance components

Declarations

Acknowledgements

We thank the participants of the AIR registry and are grateful for their participation and cooperation. We thank Veronica Vital, RN and the rest of the ASU clinical research staff for their excellent care of the participants. We thank Darwin Tsinajinnie and Martha Nunez for their technical assistance. This work was supported by Health Research Alliance Arizona and the Center for Metabolic Biology at Arizona State University. Data management support was provided by a grant (UL1 RR024150) from the Mayo Clinic to utilize Research Electronic Data Capture (REDCap).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Kinesiology Program, School of Nutrition and Health Promotion, Arizona State University
(2)
College of Health Solutions, School for the Science of Health Care Delivery, Arizona State University
(3)
Department of Genetics, Texas Biomedical Research Institute
(4)
Department of Nutrition and UNC Nutrition Research Institute, University of North Carolina at Chapel Hill
(5)
South Texas Diabetes and Obesity Institute Edinburg Regional Academic Health Center University of Texas Health Science Center at San Antonio
(6)
Mayo/ASU Center for Metabolic and Vascular Biology
(7)
College of Nursing & Health Innovation, Arizona State University

References

  1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55.View ArticlePubMedGoogle Scholar
  2. Bouchard C. Gene-environment interactions in the etiology of obesity: defining the fundamentals. Obesity (Silver Spring). 2008;16 Suppl 3:S5–10.View ArticleGoogle Scholar
  3. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–94.Google Scholar
  4. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724–6.Google Scholar
  5. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orru M, Usala G, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3(7), e115.Google Scholar
  6. DeMenna J, Puppala S, Chittoor G, Schneider J, Kim JY, Shaibi GQ, Mandarino LJ, Duggirala R, Coletta DK. Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest. Hum Hered. 2014;78(1):47–58.Google Scholar
  7. Jonsson A, Renstrom F, Lyssenko V, Brito EC, Isomaa B, Berglund G, Nilsson PM, Groop L, Franks PW. Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2511 Finnish adults. Diabetologia. 2009;52(7):1334–8.Google Scholar
  8. Liu G, Zhu H, Lagou V, Gutin B, Stallmann-Jorgensen IS, Treiber FA, Dong Y, Snieder H. FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European- and African-American youth. BMC Med Genet. 2010;11:57.Google Scholar
  9. Kilpelainen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E, Ahmad T, Mora S, Kaakinen M, Sandholt CH, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011;8(11), e1001116.Google Scholar
  10. Lawrence JM, Mayer-Davis EJ, Reynolds K, Beyer J, Pettitt DJ, D'Agostino Jr RB, Marcovina SM, Imperatore G, Hamman RF, Group SfDiYS: Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S123–32.Google Scholar
  11. Norris JM, Langefeld CD, Talbert ME, Wing MR, Haritunians T, Fingerlin TE, Hanley AJ, Ziegler JT, Taylor KD, Haffner SM, et al. Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study. Obesity (Silver Spring). 2009;17(10):1932–41.Google Scholar
  12. Villalobos-Comparan M, Teresa Flores-Dorantes M, Teresa Villarreal-Molina M, Rodriguez-Cruz M, Garcia-Ulloa AC, Robles L, Huertas-Vazquez A, Saucedo-Villarreal N, Lopez-Alarcon M, Sanchez-Munoz F, et al. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring). 2008;16(10):2296–301.Google Scholar
  13. Wing MR, Ziegler J, Langefeld CD, Ng MC, Haffner SM, Norris JM, Goodarzi MO, Bowden DW. Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Hum Genet. 2009;125(5–6):615–26.Google Scholar
  14. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318(5855):1469–72.Google Scholar
  15. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359(24):2558–66.Google Scholar
  16. Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, Olszewska AM, Levine AS, Lindblom J, Schioth HB. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology. 2008;149(5):2062–71.Google Scholar
  17. Wahlen K, Sjolin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2008;49(3):607–11.View ArticlePubMedGoogle Scholar
  18. Zhao X, Yang Y, Sun BF, Zhao YL, Yang YG. FTO and obesity: mechanisms of association. Curr Diab Rep. 2014;14(5):486.View ArticlePubMedGoogle Scholar
  19. Wing MR, Ziegler JM, Langefeld CD, Roh BH, Palmer ND, Mayer-Davis EJ, Rewers MJ, Haffner SM, Wagenknecht LE, Bowden DW. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort. Int J Obes (Lond). 2011;35(9):1173–82.Google Scholar
  20. Walley AJ, Asher JE, Froguel P. The genetic contribution to non-syndromic human obesity. Nat Rev Genet. 2009;10(7):431–42.View ArticlePubMedGoogle Scholar
  21. Park SL, Cheng I, Pendergrass SA, Kucharska-Newton AM, Lim U, Ambite JL, Caberto CP, Monroe KR, Schumacher F, Hindorff LA, et al. Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study. Am J Epidemiol. 2013;178(5):780–90.Google Scholar
  22. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93(9):3640–3.View ArticlePubMedGoogle Scholar
  23. Moleres A, Ochoa MC, Rendo-Urteaga T, Martinez-Gonzalez MA. Azcona San Julian MC, Martinez JA, Marti A, Genoi: Dietary fatty acid distribution modifies obesity risk linked to the rs9939609 polymorphism of the fat mass and obesity-associated gene in a Spanish case–control study of children. Br J Nutr. 2012;107(4):533–8.View ArticlePubMedGoogle Scholar
  24. Demerath EW, Lutsey PL, Monda KL, Linda Kao WH, Bressler J, Pankow JS, North KE, Folsom AR. Interaction of FTO and physical activity level on adiposity in African-American and European-American adults: the ARIC study. Obesity (Silver Spring). 2011;19(9):1866–72.Google Scholar
  25. Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol. 1989;44(2):M66–73.View ArticlePubMedGoogle Scholar
  26. Ahmad S, Rukh G, Varga TV, Ali A, Kurbasic A, Shungin D, Ericson U, Koivula RW, Chu AY, Rose LM, et al. Gene x physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet. 2013;9(7), e1003607.Google Scholar
  27. US Department of Health Human Services. 2008 Physical Activity Guidelines for Americans. Atlanta, GA: Centers for Disease Control and Prevention; 2008.Google Scholar
  28. Kay MC, Carroll DD, Carlson SA, Fulton JE. Awareness and knowledge of the 2008 Physical Activity Guidelines for Americans. J Phys Act Health. 2014;11(4):693–8.View ArticlePubMedGoogle Scholar
  29. Smith PG, Day NE. The design of case–control studies: the influence of confounding and interaction effects. Int J Epidemiol. 1984;13(3):356–65.View ArticlePubMedGoogle Scholar
  30. Celis-Morales CA, Perez-Bravo F, Ibanez L, Salas C, Bailey ME, Gill JM. Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PLoS One. 2012;7(5):e36345.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Wong MY, Day NE, Luan JA, Chan KP, Wareham NJ. The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol. 2003;32(1):51–7.View ArticlePubMedGoogle Scholar
  32. Shaibi GQ, Coletta DK, Vital V, Mandarino LJ. The design and conduct of a community-based registry and biorepository: a focus on cardiometabolic health in Latinos. Clin Transl Sci. 2013;6(6):429–34.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1395–402.PubMedGoogle Scholar
  34. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7.View ArticlePubMedGoogle Scholar
  35. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–9.View ArticlePubMedGoogle Scholar
  36. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA. 2010;303(3):242–9.View ArticlePubMedGoogle Scholar
  37. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62(5):1198–211.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet. 1986;50(Pt 2):181–94.View ArticlePubMedGoogle Scholar

Copyright

© Kim et al. 2016